// App-Quantinova.ai

: Pathologic response with neoadjuvant chemotherapy, immunotherapy, and chemo-immunotherapy for muscle-invasive bladder cancer (MIBC): A systematic review and meta-analysis.

Researchers

Presenter

  • Ahsan Ayaz

Principal Investigators

  • Syed Arsalan Ahmed Naqvi

  • Nikita Tripathi

  • Hafsah Ijaz

  • Sajid Ahmad Mir

  • Parminder Singh

  • Syed A. Hussain

  • Guru P. Sonpavde

  • Bradley Alexander McGregor

  • Alan Haruo Bryce

  • Irbaz Bin Riaz

  • Praful Ravi

Medical Centers

  • Mayo Clinic, Karachi, AZ

  • University of Sheffield, Sheffield, United Kingdom

  • Dana-Farber Cancer Institute, Boston, MA

  • Nishtar Medical University, Multan, Pakistan

  • AdventHealth Cancer Institute, Orlando, FL

  • Montefiore St. Luke's Cornwall Program, Newburgh, NY

Locations

  • Pakistan

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Bladder Cancer

Biomarkers

  • N/A

Drug/Treatment

  • Cisplatin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • II/III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved